Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Pregnancies”

920 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 920 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03528694
What this trial is testing

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
AstraZeneca 1,018
Testing effectiveness (Phase 2)UnknownNCT04812002
What this trial is testing

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

Who this might be right for
Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University 20
Not applicableLooking for participantsNCT06822439
What this trial is testing

Remote Fetal Monitoring in High Risk Pregnancies

Who this might be right for
High Risk PregnancyRemote Patient MonitoringDiabetes+1 more
Beth Israel Deaconess Medical Center 50
Not applicableStudy completedNCT06716710
What this trial is testing

Intervention for Fear of Childbirth in High-Risk Pregnant Women

Who this might be right for
Threatened Premature BirthPremature Membrane RuptureGestational Hypertension+4 more
Kocaeli University 149
Testing effectiveness (Phase 2)Study completedNCT00794950
What this trial is testing

Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Tract Urothelial Carcinoma
University of Michigan 43
Early research (Phase 1)UnknownNCT04134000
What this trial is testing

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Who this might be right for
Invasive Bladder Cancer
Fundacion Oncosur 40
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Not applicableStudy completedNCT00579839
What this trial is testing

Trial of Immediate vs. Delayed Cord Clamping in the Preterm Neonate

Who this might be right for
PreTerm BirthPreTerm Neonate
University of Oklahoma 200
Very early researchEnded earlyNCT03542812
What this trial is testing

L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia

Who this might be right for
Infant,PrematureBronchopulmonary DysplasiaPulmonary Hypertension
University of Utah 16
Post-approval studies (Phase 4)Study completedNCT04599075
What this trial is testing

Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

Who this might be right for
Type 1 DiabetesPregnancy, High Risk
Gianna Wilkie 70
Not applicableUnknownNCT06656611
What this trial is testing

Mobile Outreach Screening of High-Risk Human Papillomavirus Infection in Women with Limited Access to Health Services in Seine-Saint-Denis (greater Paris Area, France)

Who this might be right for
Women's Health: Cervical Neoplasm
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 700
Early research (Phase 1)Ended earlyNCT00683553
What this trial is testing

A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)

Who this might be right for
Acute Renal FailureAcute Kidney Injury
Quark Pharmaceuticals 3
Not applicableUnknownNCT02149992
What this trial is testing

Glycemic Impact of Myo-inositol in Pregnancy

Who this might be right for
Gestational Diabetes Mellitus as Antepartum Condition
Oregon Health and Science University 40
Not applicableStudy completedNCT05148429
What this trial is testing

Prenatal Screening of Intestinal Malrotation With a Higher Risk of Volvulus.

Who this might be right for
Postnatal ComplicationMesenteric Pregnancy
University Hospital, Montpellier 30
Large-scale testing (Phase 3)Study completedNCT03138512
What this trial is testing

A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

Who this might be right for
Carcinoma, Renal Cell
Bristol-Myers Squibb 1,641
Large-scale testing (Phase 3)Study completedNCT00087022
What this trial is testing

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Heidelberg Pharma AG 864
Testing effectiveness (Phase 2)Ended earlyNCT01042795
What this trial is testing

Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy

Who this might be right for
Urothelial CarcinomaBladder Cancer
University of Michigan 7
Large-scale testing (Phase 3)Study completedNCT05149248
What this trial is testing

Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study

Who this might be right for
Cancer of Cervix
Instituto Nacional de Salud Publica, Mexico 6,000
Early research (Phase 1)Study completedNCT00004082
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Beth Israel Deaconess Medical Center
Post-approval studies (Phase 4)Study completedNCT00044720
What this trial is testing

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Who this might be right for
Chronic Kidney FailureGraft vs Host DiseaseKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 484
Next Page